HighPoint Advisor Group’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$5M Sell
12,342
-2,003
-14% -$812K 0.27% 65
2025
Q1
$6.13M Buy
14,345
+2,396
+20% +$1.02M 0.36% 48
2024
Q4
$6.49M Buy
11,949
+53
+0.4% +$28.8K 0.35% 47
2024
Q3
$7.36M Sell
11,896
-768
-6% -$475K 0.43% 38
2024
Q2
$7.79M Buy
12,664
+1,237
+11% +$761K 0.47% 37
2024
Q1
$6.75M Sell
11,427
-49
-0.4% -$28.9K 0.48% 37
2023
Q4
$6.58M Buy
+11,476
New +$6.58M 0.47% 36
2022
Q2
$4.5M Buy
+8,101
New +$4.5M 0.49% 44
2021
Q3
$4.42M Sell
7,738
-17
-0.2% -$9.71K 0.43% 44
2021
Q2
$3.91M Buy
7,755
+592
+8% +$299K 0.39% 56
2021
Q1
$3.43M Buy
7,163
+224
+3% +$107K 0.4% 54
2020
Q4
$3.4M Buy
6,939
+2,163
+45% +$1.06M 0.41% 52
2020
Q3
$2.46M Sell
4,776
-13
-0.3% -$6.69K 0.44% 54
2020
Q2
$1.72M Buy
4,789
+144
+3% +$51.8K 0.37% 59
2020
Q1
$1.53M Sell
4,645
-1,839
-28% -$604K 0.36% 64
2019
Q4
$2.19M Sell
6,484
-723
-10% -$244K 0.45% 54
2019
Q3
$2.12M Buy
7,207
+1,528
+27% +$450K 0.47% 52
2019
Q2
$1.66M Buy
5,679
+2,761
+95% +$805K 0.39% 61
2019
Q1
$793K Buy
2,918
+377
+15% +$102K 0.19% 104
2018
Q4
$637K Buy
2,541
+166
+7% +$41.6K 0.17% 139
2018
Q3
$536K Buy
2,375
+22
+0.9% +$4.97K 0.15% 152
2018
Q2
$543K Sell
2,353
-23
-1% -$5.31K 0.15% 164
2018
Q1
$516K Buy
2,376
+123
+5% +$26.7K 0.14% 168
2017
Q4
$458K Buy
2,253
+176
+8% +$35.8K 0.13% 172
2017
Q3
$397K Buy
2,077
+7
+0.3% +$1.34K 0.12% 180
2017
Q2
$365K Hold
2,070
0.12% 189
2017
Q1
$365K Buy
2,070
+42
+2% +$7.41K 0.12% 189
2016
Q4
$324K Buy
2,028
+79
+4% +$12.6K 0.1% 208
2016
Q3
$290K Sell
1,949
-1,286
-40% -$191K 0.1% 222
2016
Q2
$507K Buy
+3,235
New +$507K 0.18% 144